On February 10, Yiling Pharmaceutical Global Partner Conference was grandly held online and offline, attended by more than 60 agent representatives from nearly 30 countries and regions. Mr. Sun Xuefei, General Manager of Yiling Pharmaceutical International Trade Center, Mr. Hou Yunlong, Vice President of Hebei Institute of Integrated Traditional Chinese Medicine and Western Medicine and Researcher of the National Key Laboratory of Collateral Disease Research and Innovation of Traditional Chinese Medicine, managers of various departments of the International Trade Center, and managers of offices of the International Trade Center in different countries attended the conference.
▲Mr. Sun Xuefei, General Manager of Yiling Pharmaceutical International Trade Center, delivers a speech at the Global Partner Conference
In his speech, Mr. Sun reviewed the 30-year glorious history from a startup to present Yiling Pharmaceutical witnessed by honorary titles of “Top 100 Most Valuable Chinese Brands”, “Top 20 Most Competitive Listed Pharmaceutical Companies in China” and “Top 10 Traditional Chinese Medicine Companies in China”. Mr. Sun mentioned the remarkable progress of Yiling Pharmaceutical regarding its internationalization in 2022. He also conducted in-depth exchanges with agents from various countries on the working concepts and plans for 2023, and gave his sincere gratitude for their strong support in the past year.
“With the strong support of those agents, we have made a leap-forward development for the international market business. A number of products have gained the access to Southeast Asia, Africa, Europe, South America, North America, and other markets, with nearly 100 approvals for internationally-registered products. Our products have been registered for sale in more than 30 countries and their curative effect has been highly recognized world-wide.” Mr. Sun said.
▲Mr. Hou Yunlong, Vice President of Hebei Institute of Integrated Traditional Chinese Medicine and Western Medicine and Researcher of the National Key Laboratory of Collateral Disease Research and Innovation of Traditional Chinese Medicine, delivers an academic report entitled Collateral Disease Theory Promotes Overseas Development of Innovative Traditional Chinese Medicine at the conference
Researcher Mr. Hou Yunlong delivered an academic report entitled Collateral Disease Theory Promotes the Overseas Development of Innovative Chinese Medicines at the conference. Mr. Hou introduced to the representatives from various countries that Academician Wu Yiling had systematically established the collateral disease theory and guided the research and development of innovative traditional Chinese medicines upon the inheritance and summary of the relevant discussions by medical experts in past three thousand years. Mr. Hou also stated that Academician Wu Yiling verified the efficacy of innovative traditional Chinese medicines with scientific and informative evidence-based medical facts, thus promoting the innovative traditional Chinese medicines to continuously be recognized by overseas experts and patients.
At the conference, representatives from AHKW Hong, Hong Kong CHUAN CHIONG ENTERPRISES LIMITED, Singapore Kinhong Pte Ltd, Turkey Turkishdoc Health and Turkishdoc Pharma Company, Nigeria FARMASINO Company, Kyrgyzstan Unite Pharmaceuticals Company, Canada 6 Degrees Natural Health Company Limited, the United States Hygia Healthcare Inc., and other agents shared their experiences on the sales and market conditions of Yiling innovative traditional Chinese medicines and health products. They said that they were very honored to cooperate with Yiling Pharmaceutical and hoped to maintain close cooperation and move forward together in the new development era of the international medical and health industry, to jointly promote Chinese medicine to the world for the benefit of human health.
In recognition of the outstanding achievements made by agents from various countries in sales and marketing, the conference has specially set up an award ceremony. Hong Kong CHUAN CHIONG ENTERPRISES LIMITED, AHKW Hong, and Singapore Kinhong Pte Ltd, Singapore Kinhong Pte Ltd won the gold medal; Canada 6 Degrees Natural Health, KWOK SHING HONG MEDICINE CO., LTD, Kyrgyzstan Unite Pharmaceuticals Company, Kuwait Sour Alsain Arab International General Trading Company, Thailand Enwei Group, Vietnam Tunglinh Pharmaceutical Joint Stock Company won the silver award; agents from the United States, Nicaragua, Romania, Italy, Serbia, Moldova, Ukraine, Georgia, Kazakhstan, Russia, Turkey, Belarus, Pakistan, Malaysia, Indonesia, Philippines, Mongolia, Viet Nam, Macao, Uganda, Mauritius, Nigeria, Kenya and South Africa received honorary awards.
▲On behalf of the Company, Mr. Sun Xuefei, General Manager of Yiling Pharmaceutical International Trade Center, signed contracts with Singapore Kinhong Pte Ltd, Canada 6 Degrees Natural Health Limited, the United States Hygia Healthcare Inc., and Kyrgyzstan Unite Pharmaceuticals Company respectively.
The signing ceremony of new agents and new orders was held ceremoniously at the closing moment of the conference. On behalf of the Company, Mr. Sun Xuefei, General Manager of Yiling Pharmaceutical International Trade Center, signed related order agreements with Singapore Kinhong Pte Ltd, Canada 6 Degrees Natural Health Limited, the United States Hygia Healthcare Inc., and Kyrgyzstan Unite Pharmaceuticals Company respectively. Mr. Sun Xuefei said that the internationalization of traditional Chinese medicine has a long way to go and hoped to join hands with partners in various countries to explore the best path and method for the internationalization development, thus jointly promoting the smooth development of traditional Chinese medicine and massive health products in the world and achieving mutual benefit and win-win results with partners in various countries.